,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
asco22: enhertu aces key her2-low test in breast cancer 
The original site for employees in pharma, medical, and diagnostic sales and related industries. Join us and stay informed.